Overview

Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency

Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the correlation between HbA1c and iron status in Type 2 Diabetes mellitus patients with iron deficiency by intravenous substitution of iron.
Phase:
Phase 3
Details
Lead Sponsor:
GWT-TUD GmbH
Collaborator:
Vifor Pharma
Treatments:
Ferric Compounds